ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
ASX quarterly rebalance: A2 Milk dumped from ASX 50, Nuix kicked out of ASX 200
How to invest
How to turn $20,000 into $475,000 in 10 years with ASX shares
Healthcare Shares
If you invested $1,000 in ResMed (ASX:RMD) shares a decade ago, here's what they would be worth now
Blue Chip Shares
3 top ASX 200 shares that could be buys
Share Gainers
Will the ResMed (ASX:RMD) share price continue its massive bull run?
Share Market News
Top broker names 3 ASX 200 shares to buy
Growth Shares
3 ASX growth shares that analysts love
Share Market News
Revealed: The biggest shocker from results season
Blue Chip Shares
2 top blue chip ASX shares rated as buys
Share Gainers
Why Domain, Money3, ResMed, & Steadfast shares are charging higher
Share Gainers
ResMed (ASX:RMD) share price hits record high on new product release
Broker Notes
Leading brokers name 3 ASX shares to buy today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
